TLR9 and neoplasm: It is possible that primary tumor RT effectively generates a local tumor antigen pool for APCs [38], such as, TLR9 agonist-activated pDCs, which then uptake the tumor antigens and migrates to the lymph nodes where it stimulates the Th2 cells to elicit a humoral immune response.